Equity of prescribing: A pharmaceutical issue?

Pharmaceutical Journal

Volumn 259, Issue 6968 SUPPL., 1997, Pages

  Bradshaw, Nicola ^a   Walker, Roger ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; STATIN;

ARTICLE; DRUG EFFICACY; HEALTH CARE AVAILABILITY; HEALTH SERVICE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PHARMACIST; PRESCRIPTION;

EID: 0030733704     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Payne N, Saul C. Variations in use of cardiology services in a health authority: comparison of coronary artery revascularisation rates with prevalence of angina and coronary mortality. British Medical Journal 1997; 314: 257-261.
2. Kjekshus J, Pederson TR, Tobert JA. Lipid-lowering therapy for patients with or at risk of coronary artery disease. Current Opinion in Cardiology 1996; 11: 418-427.
3. Townsend P, Phillimore P, Beattie A. Health and deprivation: Inequality and the North. London: Routledge, 1988.